genfit.com (GNFT) - Koefisien utang jangka dawa marang modal

The price trajectory of Genfit S.A. (GNFT), which specializes in therapies for rare liver pathologies, shows a value of 0.00. Management has effectively executed a restructuring and focused on seeking partners for drug commercialization. However, success depends on test results and pressure from major competitors. To reduce reliance on external laboratories, Genfit S.A. (GNFT) is implementing digital monitoring of its pool of various contractors.

The high cost of biotechnological oncology research and stringent FDA oversight require significant capital expenditures from Genfit S.A. (GNFT). The ratio of long-term liabilities to net assets, reflected through the change in long-term debt to equity, measures the company's reliance on borrowed funds with maturities exceeding one year, allowing for an assessment of the risk of overpaying for resources amid declining capitalization.